As of May 01
| +0.38 / +4.34%|
The 7 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 24.00 and a low estimate of 8.00. The median estimate represents a +75.25% increase from the last price of 9.13.
The current consensus among 8 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.